6881

SHH:688108

Sino Medical Sciences Technology Inc.

  • Stock

CNY

Last Close

7.99

30/08 07:00

Market Cap

3.70B

Beta: 0.67

Volume Today

9.57M

Avg: 6.69M

PE Ratio

−31.40

PFCF: −33.74

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
26.37M
-
43.35M
64.41%
61.13M
40.99%
66.56M
8.89%
74.81M
12.40%
91.50M
22.31%
49.06M
46.38%
average payables
27.56M
-
37.65M
36.63%
32.36M
14.05%
33.49M
3.49%
32.20M
3.86%
25.89M
19.59%
14.18M
45.25%
average receivables
97.15M
-
105.88M
8.99%
99.81M
5.74%
96.27M
3.55%
69.10M
28.22%
41.90M
39.37%
21.06M
49.73%
book value per share
0.99
-
2.66
168.48%
1.97
26.10%
2.93
48.96%
2.40
18.17%
2.27
5.24%
2.09
8.10%
capex per share
-0.22
-
-0.33
54.36%
-0.28
17.10%
-0.48
73.16%
-0.25
47.76%
-0.39
54.66%
-0.27
29.63%
capex to depreciation
-2.79
-
-4.31
54.73%
-4.77
10.57%
-6.42
34.54%
-2.94
54.13%
-2.42
17.73%
-1.75
27.61%
capex to operating cash flow
-1.05
-
-1.08
3.35%
-1.01
6.54%
-1.31
29.10%
-1.60
22.24%
2.63
264.74%
1.00
62.24%
capex to revenue
-0.17
-
-0.24
41.91%
-0.26
9.75%
-0.41
58.91%
-0.34
16.60%
-0.82
136.68%
-0.57
29.55%
cash per share
0.21
-
0.47
120.48%
1.05
123.07%
1.70
61.88%
1.15
32.22%
0.49
57.19%
0.50
1.49%
days of inventory on hand
189.67
-
230.19
21.36%
292.20
26.94%
335.31
14.75%
359.07
7.09%
609.03
69.62%
503.51
17.33%
days payables outstanding
176.33
-
256.69
45.57%
209.88
18.23%
127.63
39.19%
227.18
78.00%
168.16
25.98%
145.47
13.49%
days sales outstanding
118.37
-
122.59
3.56%
99.41
18.91%
80.39
19.14%
107.61
33.87%
78.26
27.28%
79.72
1.87%
debt to assets
0.00
-
0.00
55.21%
0.00
28.16%
-0.00
100.00%
0.04
-
0.05
36.08%
debt to equity
0.01
-
0.00
62.14%
0.00
29.47%
-0.00
100.00%
0.05
-
0.07
44.26%
dividend yield
0.00
-
0.00
49.53%
0.01
-
0.00
99.87%
0.00
4,520.90%
earnings yield
0.01
-
0.01
107.14%
0.01
13.79%
0.01
31.13%
0.00
74.85%
-0.04
1,154.32%
-0.07
91.05%
enterprise value
4.50B
-
4.96B
10.15%
7.55B
52.22%
5.46B
27.66%
5.52B
0.98%
3.11B
43.58%
2.17B
30.17%
enterprise value over ebitda
78.32
-
49.58
36.69%
59.69
20.39%
41.35
30.72%
102.77
148.50%
-35.83
134.87%
-15.54
56.62%
ev to operating cash flow
106.58
-
70.53
33.83%
77.38
9.72%
39.69
48.71%
78.21
97.05%
-51.74
166.16%
-19.52
62.27%
ev to sales
16.95
-
15.40
9.14%
19.85
28.85%
12.53
36.87%
16.84
34.44%
16.01
4.96%
11.27
29.62%
free cash flow per share
-0.01
-
-0.03
155.98%
-0.00
85.86%
-0.11
2,975.38%
-0.09
16.94%
-0.53
469.29%
-0.55
2.27%
free cash flow yield
-0.00
-
-0.00
155.98%
-0.00
85.86%
-0.01
4,100.75%
-0.01
0.26%
-0.07
834.02%
-0.10
47.05%
graham net net
0.20
-
0.44
126.06%
1.05
136.38%
1.70
61.73%
1.08
36.68%
0.29
73.26%
0.26
10.98%
graham number
1.77
-
4.17
135.83%
3.33
20.18%
3.98
19.58%
1.64
58.71%
4.05
146.77%
4.48
10.50%
income quality
1.47
-
1.06
27.90%
1.09
2.89%
1.53
39.72%
3.13
105.12%
0.46
85.39%
0.64
40.24%
intangibles to total assets
0.27
-
0.16
39.81%
0.20
26.16%
0.21
5.00%
0.25
17.14%
0.29
13.94%
0.33
16.47%
0
100%
interest coverage
112.70
-
-188.00
266.82%
-67.19
64.26%
-22.51
66.49%
-2.66
88.20%
-70.95
2,571.74%
-78.47
10.60%
interest debt per share
0.01
-
0.00
52.02%
-0.00
157.34%
-0.01
597.50%
-0.01
0.02%
0.11
984.35%
0.15
31.82%
inventory turnover
1.92
-
1.59
17.60%
1.25
21.22%
1.09
12.86%
1.02
6.62%
0.60
41.04%
0.72
20.96%
invested capital
0.01
-
0.00
62.14%
0.00
29.47%
-0.00
100.00%
0.05
-
0.07
44.26%
market cap
4.55B
-
5.07B
11.46%
7.92B
56.41%
6.10B
23.01%
6.06B
0.66%
3.35B
44.63%
2.32B
30.91%
net current asset value
72.66M
-
405.89M
458.61%
430.54M
6.07%
699.77M
62.53%
583.80M
16.57%
272.88M
53.26%
174.77M
35.95%
net debt to ebitda
-0.74
-
-1.06
43.07%
-2.96
178.27%
-4.83
63.44%
-10.15
109.97%
2.80
127.63%
1.04
62.98%
net income per share
0.14
-
0.29
107.14%
0.25
13.79%
0.24
4.00%
0.05
79.17%
-0.32
742.61%
-0.43
32.87%
operating cash flow per share
0.21
-
0.31
49.36%
0.27
11.30%
0.37
34.13%
0.16
57.27%
-0.15
193.88%
-0.27
86.34%
payables turnover
2.07
-
1.42
31.30%
1.74
22.30%
2.86
64.45%
1.61
43.82%
2.17
35.09%
2.51
15.60%
receivables turnover
3.08
-
2.98
3.44%
3.67
23.32%
4.54
23.66%
3.39
25.30%
4.66
37.52%
4.58
1.84%
research and ddevelopement to revenue
0.29
-
0.17
41.74%
0.17
4.94%
0.21
17.49%
0.33
61.58%
0.77
130.74%
0.79
3.39%
return on tangible assets
0.14
-
0.11
20.34%
0.14
25.11%
0.09
31.63%
0.02
74.05%
-0.17
775.71%
-0.24
45.97%
-0.04
82.88%
revenue per share
1.30
-
1.41
8.77%
1.07
24.47%
1.16
8.97%
0.73
37.36%
0.48
34.65%
0.48
0.12%
roe
0.14
-
0.11
22.85%
0.13
16.65%
0.08
35.55%
0.02
74.54%
-0.14
778.11%
-0.20
44.58%
-0.06
70.21%
roic
0.13
-
0.11
15.98%
0.13
20.42%
0.08
38.48%
0.01
86.51%
-0.13
1,230.79%
-0.17
35.85%
-0.06
64.33%
sales general and administrative to revenue
0.13
-
0.19
39.04%
0.05
70.98%
0.05
16.18%
0.06
27.33%
0.13
126.04%
0.15
12.34%
shareholders equity per share
0.99
-
2.66
168.48%
1.97
26.10%
2.93
48.96%
2.40
18.17%
2.27
5.24%
2.09
8.10%
stock based compensation to revenue
tangible asset value
127.52M
-
492.16M
285.95%
537.29M
9.17%
841.00M
56.53%
773.25M
8.06%
630.69M
18.44%
532.98M
15.49%
1.19B
122.42%
tangible book value per share
0.62
-
2.16
246.29%
1.51
30.20%
2.24
48.85%
1.72
23.32%
1.54
10.21%
1.31
14.93%
working capital
86.90M
-
422.22M
385.87%
452.29M
7.12%
727.70M
60.89%
631.26M
13.25%
338.24M
46.42%
222.72M
34.15%

All numbers in CNY (except ratios and percentages)